Related references
Note: Only part of the references are listed.Histone deacetylases, Mbd3/NuRD, and Tet2 hydroxylase are crucial regulators of epithelial-mesenchymal plasticity and tumor metastasis
Ayse Nihan Kilinc et al.
ONCOGENE (2020)
Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer
Ashenafi Bulle et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Emerging Mechanisms by which EMT Programs Control Stemness
Molly M. Wilson et al.
TRENDS IN CANCER (2020)
The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer
Charlotte Dahlem et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death
Kyung-A Song et al.
JOURNAL OF THORACIC DISEASE (2019)
Mechanisms of acquired tumor drug resistance
Svetlana N. Aleksakhina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Chromodomain Helicase DNA-Binding Protein 7 Is Suppressed in the Perinecrotic/Ischemic Microenvironment and Is a Novel Regulator of Glioblastoma Angiogenesis
Nathaniel H. Boyd et al.
STEM CELLS (2019)
The Reactome Pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Gwen Lomberk et al.
NATURE COMMUNICATIONS (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
Co-repressor, co-activator and general transcription factor: the many faces of the Sin3 histone deacetylase (HDAC) complex
Grace E. Adams et al.
BIOCHEMICAL JOURNAL (2018)
Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib
Wenwen Chien et al.
JOURNAL OF CANCER (2018)
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Elisabeth Hessmann et al.
GUT (2017)
Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
Zachary Steinhart et al.
NATURE MEDICINE (2017)
The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer
Ming-Feng Hou et al.
EXPERIMENTAL CELL RESEARCH (2017)
Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing Assay
Ayman Grada et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
Oliver G. McDonald et al.
NATURE GENETICS (2017)
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
Julia Joung et al.
NATURE PROTOCOLS (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4
Marie K. Kirby et al.
MOLECULAR ONCOLOGY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
Bastiaan Evers et al.
NATURE BIOTECHNOLOGY (2016)
Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
David W. Morgens et al.
NATURE BIOTECHNOLOGY (2016)
The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells
Vikash J. Bhagwandin et al.
PLOS ONE (2016)
Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis
Xing Shugang et al.
TRANSLATIONAL ONCOLOGY (2016)
The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing
Nils Degrauwe et al.
CELL REPORTS (2016)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Silvana Konermann et al.
NATURE (2015)
Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
Ignacio Garrido-Laguna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Optimizing Cancer Genome Sequencing and Analysis
Malachi Griffith et al.
CELL SYSTEMS (2015)
A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells
V. Bhattacharjee et al.
CELL CYCLE (2014)
TIMP-1 via TWIST1 Induces EMT Phenotypes in Human Breast Epithelial Cells
Rosemarie Chirco D'Angelo et al.
MOLECULAR CANCER RESEARCH (2014)
Comparative Proteomic Profiling of Pancreatic Ductal Adenocarcinoma Cell Lines
Yikwon Kim et al.
MOLECULES AND CELLS (2014)
A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response
Scott C. Smith et al.
NUCLEIC ACIDS RESEARCH (2014)
Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK
Hashem A. Dbouk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia
Stephen G. Landt et al.
GENOME RESEARCH (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells
Lei You et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Annexin A1 attenuates EMT and metastatic potential in breast cancer
Sabine Maschler et al.
EMBO MOLECULAR MEDICINE (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
Zhiwei Wang et al.
CANCER RESEARCH (2009)
The Drosophila tumor suppressor vps25 prevents nonautonomous overproliferation by regulating Notch trafficking
T Vaccari et al.
DEVELOPMENTAL CELL (2005)